肿瘤细胞治疗研究
ALL SOURCES
Engineering CLL-1 CAR-NK cells via mRNA-LNP for potent antitumor activity and reversal of HLA-E-mediated resistance in acute myeloid leukemia.
瞬时、非整合的 mRNA LNP 转染的 CLL-1 CAR-NK 细胞为 MDR AML 提供了一种安全有效的策略。
Safety and efficacy of the mRNA BNT162b2 vaccine against SARS-CoV-2 in five groups of immunocompromised patients and healthy controls in a prospective
结果显示，mRNA BNT162b2 疫苗在免疫功能低下患者中是安全的。
Humoral and T-cell immune responses to coronavirus disease 2019 vaccines in patients with hematological malignancies.
本研究提供了确证性真实世界证据，表明CD19恢复是体液应答的关键决定因素，而疫苗诱导的T细胞免疫即使在抗体无应答者中也可能得以保留，支持在这一高风险人群中继续开展疫苗接种工作。
Vaccination for SARS-CoV-2 in Hematological Patients.
非霍奇金淋巴瘤和慢性淋巴细胞白血病患者接种 mRNA 疫苗后的血清阳性率达到 40%-50%。
共 4 条
MEMBER ACCOUNT
登录成功会直接打开下一页。
